The results show that SHISA3 promoter methylation is significantly associated with histological grade (P = 0.02), clinical stage (P = 0.02), tumor stage (P = 0.05), and lymph node metastasis (P = 0.03). The gene discussed is SHISA3; the disease is metastatic malignant neoplasm in the lymph nodes.